PharmaResearch Co., Ltd. (KOSDAQ: 214450)
184,600
-3,700 (-1.96%)
Sep 11, 2024, 9:00 AM KST
PharmaResearch Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Net Income | 90,744 | 76,551 | 40,577 | 46,689 | 32,774 | 16,667 | Upgrade
|
Depreciation & Amortization | 12,514 | 11,996 | 10,602 | 9,552 | 8,360 | 7,683 | Upgrade
|
Loss (Gain) From Sale of Assets | 1.46 | -36.11 | 5,846 | -229.6 | 362.6 | -7.05 | Upgrade
|
Asset Writedown & Restructuring Costs | 3,120 | 3,120 | - | 839.66 | 1,246 | - | Upgrade
|
Loss (Gain) From Sale of Investments | 10,716 | -3,042 | 2,259 | -943.49 | 261.14 | -349.41 | Upgrade
|
Loss (Gain) on Equity Investments | -7,277 | -680.03 | 2,192 | -556.93 | -3,168 | 980.24 | Upgrade
|
Stock-Based Compensation | 658.9 | 657.1 | 505.88 | - | - | 2.92 | Upgrade
|
Provision & Write-off of Bad Debts | 417.89 | 582.21 | 290.45 | -406.73 | -1,309 | -332.63 | Upgrade
|
Other Operating Activities | -1,134 | 6,512 | 7,598 | 1,932 | 4,037 | 3,686 | Upgrade
|
Change in Accounts Receivable | 2,026 | 717.13 | -4,843 | -3,842 | -1,040 | -3,557 | Upgrade
|
Change in Inventory | -14,783 | -28,188 | -8,374 | 2,927 | -8,247 | -3,960 | Upgrade
|
Change in Accounts Payable | 1,819 | -559.07 | 597.78 | 397.75 | -3,622 | 504.46 | Upgrade
|
Change in Unearned Revenue | -9.47 | 16.32 | 11.36 | - | - | -91.67 | Upgrade
|
Change in Income Taxes | 354.7 | - | 9.63 | 1.52 | -2.43 | 3.62 | Upgrade
|
Change in Other Net Operating Assets | 4,928 | -3,230 | 2,131 | 9,088 | 2,936 | -1,332 | Upgrade
|
Operating Cash Flow | 104,279 | 64,945 | 59,404 | 65,297 | 32,392 | 19,272 | Upgrade
|
Operating Cash Flow Growth | 82.05% | 9.33% | -9.03% | 101.59% | 68.07% | 270.38% | Upgrade
|
Capital Expenditures | -25,082 | -12,063 | -17,257 | -20,645 | -34,785 | -9,586 | Upgrade
|
Sale of Property, Plant & Equipment | -91.61 | 28.65 | 734.02 | - | 0.83 | 24.09 | Upgrade
|
Cash Acquisitions | - | - | -35.01 | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -2,386 | -623.05 | -460.83 | -2,786 | -597.98 | -197.89 | Upgrade
|
Investment in Securities | -31,628 | -31,860 | 5,446 | -66,427 | -3,630 | 1,267 | Upgrade
|
Other Investing Activities | -1,392 | -522.63 | -794.6 | -590.91 | 1,822 | -559.97 | Upgrade
|
Investing Cash Flow | -59,892 | -44,668 | -11,908 | -93,755 | -36,209 | -11,637 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 15,000 | - | Upgrade
|
Long-Term Debt Issued | - | - | - | 50,000 | 162.61 | - | Upgrade
|
Total Debt Issued | 10,675 | - | - | 50,000 | 15,163 | - | Upgrade
|
Short-Term Debt Repaid | - | -15,150 | -860 | -29.13 | - | - | Upgrade
|
Long-Term Debt Repaid | - | -3,649 | -2,126 | -1,976 | -1,110 | -963.71 | Upgrade
|
Total Debt Repaid | -17,756 | -18,799 | -2,986 | -2,005 | -1,110 | -963.71 | Upgrade
|
Net Debt Issued (Repaid) | -7,081 | -18,799 | -2,986 | 47,995 | 14,053 | -963.71 | Upgrade
|
Issuance of Common Stock | - | 359.24 | - | - | - | - | Upgrade
|
Repurchase of Common Stock | - | - | - | - | - | -4,992 | Upgrade
|
Dividends Paid | -10,472 | -7,529 | -6,316 | -5,030 | -2,965 | -2,973 | Upgrade
|
Other Financing Activities | -151.2 | -0 | - | -0 | - | -175.13 | Upgrade
|
Financing Cash Flow | -17,704 | -25,969 | -9,301 | 42,965 | 11,088 | -9,104 | Upgrade
|
Foreign Exchange Rate Adjustments | 291.71 | 4.41 | -76.12 | 300.33 | -293.87 | 110.98 | Upgrade
|
Miscellaneous Cash Flow Adjustments | 0 | 0 | -6,862 | 151.51 | - | -0 | Upgrade
|
Net Cash Flow | 26,975 | -5,687 | 31,257 | 14,959 | 6,977 | -1,358 | Upgrade
|
Free Cash Flow | 79,197 | 52,883 | 42,147 | 44,652 | -2,393 | 9,687 | Upgrade
|
Free Cash Flow Growth | 78.01% | 25.47% | -5.61% | - | - | - | Upgrade
|
Free Cash Flow Margin | 26.70% | 20.26% | 21.64% | 28.98% | -2.20% | 11.55% | Upgrade
|
Free Cash Flow Per Share | 7021.02 | 5008.17 | 4224.85 | 4441.83 | -251.75 | 1026.37 | Upgrade
|
Cash Interest Paid | 425.99 | 493.61 | 159.45 | 196.15 | 116.99 | 183.63 | Upgrade
|
Cash Income Tax Paid | 17,573 | 16,962 | 13,798 | 10,051 | 5,862 | 2,490 | Upgrade
|
Levered Free Cash Flow | 44,264 | 21,153 | 25,115 | 27,225 | -18,756 | 5,871 | Upgrade
|
Unlevered Free Cash Flow | 45,102 | 23,020 | 27,509 | 28,046 | -17,640 | 7,335 | Upgrade
|
Change in Net Working Capital | 5,758 | 33,951 | 6,573 | -9,119 | 11,508 | 2,478 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.